We used the ssGSEA algorithm to estimate the abundance of Tumor-Infiltrating Immune Cells (TIICs) in the TME, and the results demonstrated GPX4 was positively associated with most TIICs in patients with COAD (Fig. 1G). This evidence concerns the gene GPX4 and colon adenocarcinoma.